Metformin Attenuates Liver Fat Content: Finding from Schizophrenia Patients with Olanzapine-induced Weight Gain

OBJECTIVE: This study was performed to evaluate the efficacy of metformin on liver fat content (LFC) in first episode schizophrenia patients with olanzapine-induced weight gain, and the relationship between the change of LFC and the other metabolic indices. METHODS: In a double-blind study, the clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Chen, Yu, Sui, Yun-chuan, Tan, Xing-qi, Zhou, Zhi, Li, Ning, Xu, Le-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006974/
https://www.ncbi.nlm.nih.gov/pubmed/31958907
http://dx.doi.org/10.9758/cpn.2020.18.1.67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006974/
https://www.ncbi.nlm.nih.gov/pubmed/31958907
http://dx.doi.org/10.9758/cpn.2020.18.1.67

Ejemplares similares